Gene · 553
AVPR1B: arginine vasopressin receptor 1B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AVPR1B: arginine vasopressin receptor 1B. Genes, record 553. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/553
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P47901 | Vasopressin V1b receptor | 424 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026062654 A | 2026-04-10 | 57 | P47901 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37810 | P47901 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8334 | P47901 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 550 | P47901 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 550 | P47901 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8334 | P47901 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 6183 | P47901 | Espacenet |
| JP 2023156353 A | 2023-10-24 | 57 | P47901 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 6183 | P47901 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 207 | P47901 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs8
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
| Drug | ChEMBL ID | Mechanism | Action | Source |
|---|---|---|---|---|
| ARGIPRESSIN TANNATE | CHEMBL2108986 | Vasopressin receptor agonist | AGONIST | ChEMBL |
| DESMOPRESSIN | CHEMBL1429 | Vasopressin receptor agonist | AGONIST | ChEMBL |
| DESMOPRESSIN ACETATE | CHEMBL1200556 | Vasopressin receptor agonist | AGONIST | ChEMBL |
| LYPRESSIN | CHEMBL1200690 | Vasopressin receptor agonist | AGONIST | ChEMBL |
| NELIVAPTAN | CHEMBL582857 | Vasopressin V1b receptor antagonist | ANTAGONIST | ChEMBL |
| TERLIPRESSIN | CHEMBL2135460 | Vasopressin V1 receptor binding agent | BINDING AGENT | ChEMBL |
| VASOPRESSIN | CHEMBL373742 | Vasopressin receptor agonist | AGONIST | ChEMBL |
| VASOPRESSIN TANNATE | CHEMBL1201528 | Vasopressin V1b receptor agonist | AGONIST | ChEMBL |
Trials142
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07460908 | TERLIPRESSIN | ClinicalTrials.gov | ||
| NCT07423156 | VASOPRESSIN | PHASE3 | ClinicalTrials.gov | |
| NCT07304466 | TERLIPRESSIN | ClinicalTrials.gov | ||
| NCT07255378 | VASOPRESSIN | ClinicalTrials.gov | ||
| NCT07252401 | TERLIPRESSIN | ClinicalTrials.gov | ||
| NCT07233850 | TERLIPRESSIN | PHASE2 | ClinicalTrials.gov | |
| NCT07179991 | DESMOPRESSIN | ClinicalTrials.gov | ||
| NCT07052084 | VASOPRESSIN | PHASE3 | ClinicalTrials.gov | |
| NCT07028645 | DESMOPRESSIN | ClinicalTrials.gov | ||
| NCT06855758 | TERLIPRESSIN | ClinicalTrials.gov |
1 to 10 of 142
See all 142 trialsNIH grants415
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AVPR1B papers | Newest fiscal year |
|---|---|---|---|
| P51OD011132 | Emory National Primate Research Center | 6 | 2025 |
| P60AA006420 | CNS Effects of Alcohol: Cellular Neurobiology | 3 | 2025 |
| I01BX002773 | A Novel Drug Target for Aggressive Prostate Cancer | 2 | 2025 |
| I01BX004102 | Oxytocin Signaling in the Control of Cardiometabolic Function in Diet-Induced Obesity | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| R01HD098117 | Mechanisms of maternal brain changes with birth interventions | 2 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 2 | 2025 |
| ZIAAA000301 | Integrative genetics of behavior with high throughput technologies | 2 | 2025 |
| ZIAES100221 | Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System | 2 | 2025 |
| K01DK129417 | Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism | 1 | 2025 |
1 to 10 of 415Source NIH's project files
See all 415 nih grantsPapers572
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthetic Strategies and Biological Activities of Pyrazolo[4,3-e]pyrrolo[1,2- a]pyrazines and Related Tricyclic Systems: A Comprehensive Literature Review. | Mini Rev Med Chem | 2026 | 42764647 | PubTator, text mining | PubMed |
| Arginine-vasopressin systems in autistic phenotype schizophrenia: effect of a genetic variant of AVPR1a and AVPR1b. | J Neural Transm (Vienna) | 2026 | 42047756 | PubTator, text mining | PubMed |
| Imaging genetics insights into the association between polymorphisms of HPA-axis genes and brain function alterations in depressed adolescents. | J Affect Disord | 2026 | 41935751 | PubTator, text mining | PubMed |
| Correction: Nazarloo et al. Oxytocin, Vasopressin and Stress: A Hormetic Perspective. Curr. Issues Mol. Biol. 2025, 47, 632. | Curr Issues Mol Biol | 2026 | 41899490 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management. | Front Endocrinol (Lausanne) | 2026 | 41757229 | PubTator, text mining | PubMed |
| Reply to Lago, T.R.; Bolognani, F. Comment on "Nazarloo et al. Oxytocin, Vasopressin and Stress: A Hormetic Perspective. Curr. Issues Mol. Biol. 2025, 47, 632". | Curr Issues Mol Biol | 2026 | 41751456 | PubTator, text mining | PubMed |
| Polymorphic Variants in Oxytocin and Arginine Vasopressin Receptors in a Pediatric Population with Autism Spectrum Disorder Diagnosis in Mexico. | Genet Test Mol Biomarkers | 2026 | 41578830 | PubTator, text mining | PubMed |
| Circulating hormonal and gene expression profile in heat-stressed broilers divergently selected for high or low water efficiency. | Poult Sci | 2026 | 41570528 | PubTator, text mining | PubMed |
| MoAGNN: a multi-omics hierarchical graph neural network for subtype classification and prognosis prediction in lung adenocarcinoma. | Brief Bioinform | 2026 | 41554048 | PubTator, text mining | PubMed |
| Toward precision psychiatry: theoretical implications of bimodal response patterns to vasopressin V1b receptor inhibition in depression. | Front Psychiatry | 2025 | 41179820 | PubTator, text mining | PubMed |
1 to 10 of 572
See all 572 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/553
GET https://conductscience.org/api/genes/v1/553/patents?page=2